Ad
related to: dabigatran approved for stroke research papers list of journals
Search results
Results from the WOW.Com Content Network
In October 2010 the US FDA approved dabigatran etexilate for the prevention of stroke in patients with atrial fibrillation (AF). [6] [10] Many pharmaceutical companies have attempted to develop orally bioavailable DTI drugs but dabigatran etexilate is the only one to reach the market. [9]
Medical journals are published regularly to communicate new research to clinicians, medical scientists, and other healthcare workers. This article lists academic journals that focus on the practice of medicine or any medical specialty. Journals are listed alphabetically by journal name, and also grouped by the subfield of medicine they focus on.
Dabigatran, sold under the brand name Pradaxa among others, is an anticoagulant used to treat and prevent blood clots and to prevent stroke in people with atrial fibrillation. [ 6 ] [ 7 ] Specifically it is used to prevent blood clots following hip or knee replacement and in those with a history of prior clots. [ 6 ]
The journals registered in this database underwent rigorous, multidimensional parameterization, proving high quality. The Ministry of Science and Higher Education acknowledged the IC Journal Master List by placing it on the list of scored databases, for being indexed in IC JML journals get additional points in the Ministry’s evaluation process.
List of psychology journals; List of psychotherapy journals; List of public administration journals; List of public relations journals; List of scientific journals; List of sexology journals; List of Slavic studies journals; List of social science journals; List of sociology journals; List of statistics journals; List of systems science journals
The following is a partial list of scientific journals. There are thousands of scientific journals in publication, and many more have been published at various points in the past. The list given here is far from exhaustive, only containing some of the most influential, currently publishing journals in each field.
Dabigatran is an oral direct thrombin inhibitor. Dabigatran (Pradaxa) was found to be noninferior to Warfarin in prevention of ischemic stroke, as well as intracranial hemorrhage risk and overall mortality for non-valvular atrial fibrillation according to the RE-LY trial. [9]
Health Services Management Research; Human Resources for Health; Journal for Healthcare Quality; Journal of Healthcare Management; Journal of Innovation in Health Informatics; Journal of Medical Marketing
Ad
related to: dabigatran approved for stroke research papers list of journals